These findings revealed a novel function of Anxa2 in cerebral I/R injury and indicated that intervening in target Anxa2 expression in microglia may be a potential therapeutic strategy for alleviating the pathological progression of cerebral ischemia. The gene discussed is ANXA2; the disease is brain ischemia.